Sato S - Search Results

1

Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.

Sato S, Hasegawa M, Takehara K. Sato S, et al. J Dermatol Sci. 2001 Oct;27(2):140-6. doi: 10.1016/s0923-1811(01)00128-1. J Dermatol Sci. 2001. PMID: 11532378

2

[The titers and complement-activating abilities of anticentromere antibody in systemic sclerosis, other connective tissue diseases, and other related conditions].

Sato S, Takehara K, Ishibashi Y. Sato S, et al. Nihon Hifuka Gakkai Zasshi. 1991 Feb;101(2):97-104. Nihon Hifuka Gakkai Zasshi. 1991. PMID: 2072581 Japanese.

3

Detection of antiribosomal P protein antibodies in patients with systemic sclerosis.

Fujimoto M, Sato S, Takehara K, Nojima Y, Soma Y, Kikuchi K, Ihn H, Igarashi A, Tamaki K. Fujimoto M, et al. Among authors: sato s. Br J Rheumatol. 1995 Oct;34(10):908-11. doi: 10.1093/rheumatology/34.10.908. Br J Rheumatol. 1995. PMID: 7582693

4

Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma.

Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Sato S, et al. J Am Acad Dermatol. 1994 Oct;31(4):567-71. doi: 10.1016/s0190-9622(94)70217-9. J Am Acad Dermatol. 1994. PMID: 8089281

5

A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.

Sato S, Ihn H, Soma Y, Shimozuma M, Shishiba T, Takehara K. Sato S, et al. J Rheumatol. 1993 Nov;20(11):1961-3. J Rheumatol. 1993. PMID: 8308786

6

Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders.

Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, Grotendorst GR, Takehara K. Igarashi A, et al. Among authors: sato s. J Invest Dermatol. 1996 Apr;106(4):729-33. doi: 10.1111/1523-1747.ep12345771. J Invest Dermatol. 1996. PMID: 8618012

7

Distribution of anti-p80-coilin autoantibody in collagen diseases and various skin diseases.

Fujimoto M, Kikuchi K, Tamaki T, Yazawa N, Kubo M, Ihn H, Sato S, Soma Y, Tamaki K. Fujimoto M, et al. Among authors: sato s. Br J Dermatol. 1997 Dec;137(6):916-20. Br J Dermatol. 1997. PMID: 9470907

8

Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.

Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Hasegawa M, et al. Among authors: sato s. J Rheumatol. 1998 Feb;25(2):308-13. J Rheumatol. 1998. PMID: 9489824

9

High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement.

Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K. Yazawa N, et al. Among authors: sato s. J Rheumatol. 1998 Apr;25(4):650-3. J Rheumatol. 1998. PMID: 9558164

10

Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis.

Ihn H, Sato S, Fujimoto M, Takehara K, Tamaki K. Ihn H, et al. Among authors: sato s. Br J Rheumatol. 1998 Nov;37(11):1188-92. doi: 10.1093/rheumatology/37.11.1188. Br J Rheumatol. 1998. PMID: 9851267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results